Resultados de la búsqueda 221-230 of 11301 for pneumococcal vaccination

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Expanded ...

  3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    T Cell Response to COVID19 Vaccinated Individuals. Rochester, Minn., Jacksonville, Fla. The first aim of this study is to verify that the TCR beta sequencing ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  5. Vacuna contra la COVID-19: ¿Debo cambiar mi cita para el mamograma? - Mayo Clinic

    Show References. SBI recommendations for the management of axillary adenopathy in patients with recent COVD-19 vaccination. Society of Breast Imaging. https:// ...

  6. Salud de la mujer Noticias de la Mayo Clinic - Mayo Clinic

    (VIDEO) Vaccines and viruses: Protecting health across generations Sept. 26, 2025, 04:28 p.m. CDT · Mayo Clinic recommendations for 2025-26 COVID-19 vaccines ...

  7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    T Cell Response to COVID19 Vaccinated Individuals. Rochester, Minn., Jacksonville, Fla. The first aim of this study is to verify that the TCR beta sequencing ...

  8. Historia del sarampión: línea cronológica de brotes y vacunas

    JAMA. 1971;218:57. Klein NP. Licensed pertussis vaccine in the United States: History and current state (Vacuna autorizada contra la tos ferina en los Estados ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Collecting ...